US5045468A
(en)
|
1986-12-12 |
1991-09-03 |
Cell Enterprises, Inc. |
Protein-free culture medium which promotes hybridoma growth
|
SU1484094A1
(ru)
*
|
1987-04-03 |
1994-01-15 |
Институт биоорганической химии АН БССР |
Способ очистки антител к тиреоидным гормонам
|
US6048728A
(en)
|
1988-09-23 |
2000-04-11 |
Chiron Corporation |
Cell culture medium for enhanced cell growth, culture longevity, and product expression
|
US5110913A
(en)
|
1990-05-25 |
1992-05-05 |
Miles Inc. |
Antibody purification method
|
US5096816A
(en)
|
1990-06-05 |
1992-03-17 |
Cetus Corporation |
In vitro management of ammonia's effect on glycosylation of cell products through pH control
|
EP0666312A1
(en)
|
1994-02-08 |
1995-08-09 |
Wolfgang A. Renner |
Process for the improvement of mammalian cell growth
|
US5429746A
(en)
|
1994-02-22 |
1995-07-04 |
Smith Kline Beecham Corporation |
Antibody purification
|
US5853714A
(en)
*
|
1995-03-27 |
1998-12-29 |
Genetics Institute, Inc. |
Method for purification of IL-12
|
US5641870A
(en)
|
1995-04-20 |
1997-06-24 |
Genentech, Inc. |
Low pH hydrophobic interaction chromatography for antibody purification
|
US6656466B1
(en)
|
1995-06-06 |
2003-12-02 |
Genetech, Inc. |
Human tumor necrosis factor—immunoglobulin(TNFR1-IgG1) chimera composition
|
US5721121A
(en)
|
1995-06-06 |
1998-02-24 |
Genentech, Inc. |
Mammalian cell culture process for producing a tumor necrosis factor receptor immunoglobulin chimeric protein
|
US5705364A
(en)
|
1995-06-06 |
1998-01-06 |
Genentech, Inc. |
Mammalian cell culture process
|
JP4306813B2
(ja)
|
1995-09-19 |
2009-08-05 |
アスビオファーマ株式会社 |
動物細胞の新規培養方法
|
DK0802257T3
(da)
|
1996-04-19 |
2002-10-28 |
Nestle Sa |
Udødeliggjort cellelinie fra epitelceller i human colon
|
WO1998017786A1
(en)
|
1996-10-23 |
1998-04-30 |
Oravax, Inc. |
Heat inactivation of viruses in antibody preparations
|
DK0936923T3
(da)
*
|
1996-11-15 |
2004-04-26 |
Kennedy Inst Of Rheumatology |
Undertrykkelse af TNFalpha og IL-12 ved terapi
|
ATE425990T1
(de)
|
1996-11-27 |
2009-04-15 |
Genentech Inc |
Affinitatsreinigung von polypeptid-proteinen auf einer matrix
|
US6955917B2
(en)
*
|
1997-06-20 |
2005-10-18 |
Bayer Healthcare Llc |
Chromatographic method for high yield purification and viral inactivation of antibodies
|
IL121900A
(en)
|
1997-10-07 |
2001-12-23 |
Omrix Biopharmaceuticals Ltd |
A method for the purification of immunoglobulins
|
US20020045207A1
(en)
|
1997-10-31 |
2002-04-18 |
Lynne A. Krummen |
Glycoprotein production process
|
WO1999032605A1
(en)
|
1997-12-19 |
1999-07-01 |
Novo Nordisk A/S |
Method for producing heterologous proteins in eukaryotic cells on an industrial scale using nucleotide-manipulating agents
|
IL139035A0
(en)
|
1998-05-06 |
2001-11-25 |
Genentech Inc |
Protein purification by ion exchange chromatography
|
US6528286B1
(en)
|
1998-05-29 |
2003-03-04 |
Genentech, Inc. |
Mammalian cell culture process for producing glycoproteins
|
CA2276216A1
(en)
*
|
1998-06-24 |
1999-12-24 |
Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo |
An artificial peptide capable of neutralizing the biological activity of interleukin-18
|
US6914128B1
(en)
*
|
1999-03-25 |
2005-07-05 |
Abbott Gmbh & Co. Kg |
Human antibodies that bind human IL-12 and methods for producing
|
DE60025015T2
(de)
|
1999-09-27 |
2006-08-03 |
Genentech Inc., San Francisco |
Verfahren zur herstellung von rekombinanten proteinen mittels inhibitoren von apoptose
|
IL151131A0
(en)
|
2000-02-08 |
2003-04-10 |
Genentech Inc |
Improved galactosylation of recombinant glycoproteins
|
WO2001058956A2
(en)
|
2000-02-10 |
2001-08-16 |
Abbott Laboratories |
Antibodies that bind human interleukin-18 and methods of making and using
|
US7598055B2
(en)
|
2000-06-28 |
2009-10-06 |
Glycofi, Inc. |
N-acetylglucosaminyltransferase III expression in lower eukaryotes
|
EP1175931A1
(en)
|
2000-07-25 |
2002-01-30 |
Computer Cell Culture Center S.A. |
Integration of high cell density bioreactor operation with ultra fast on-line downstream processing
|
US6902734B2
(en)
|
2000-08-07 |
2005-06-07 |
Centocor, Inc. |
Anti-IL-12 antibodies and compositions thereof
|
AU2001294520A1
(en)
|
2000-08-21 |
2002-03-04 |
Clonex Development, Inc. |
Methods and compositions for increasing protein yield from a cell culture
|
US6693173B2
(en)
|
2000-12-26 |
2004-02-17 |
Alpha Therapeutic Corporation |
Method to remove citrate and aluminum from proteins
|
US20030096414A1
(en)
|
2001-03-27 |
2003-05-22 |
Invitrogen Corporation |
Culture medium for cell growth and transfection
|
CA2448788C
(en)
|
2001-06-05 |
2010-08-24 |
Genetics Institute, Llc. |
Methods for purifying highly anionic proteins
|
IL160170A0
(en)
|
2001-08-03 |
2004-07-25 |
Glycart Biotechnology Ag |
A host cell engineered to produce a polypeptide having increased cytotoxicity
|
ES2291534T3
(es)
|
2001-10-02 |
2008-03-01 |
Novo Nordisk Health Care Ag |
Metodo para la produccion de proteinas recombinantes en celulas eucariotas.
|
MXPA04003798A
(es)
|
2001-10-25 |
2004-07-30 |
Genentech Inc |
Composiciones de glicoproteina.
|
EP2308888B1
(en)
*
|
2001-11-14 |
2017-03-01 |
Janssen Biotech, Inc. |
Anti-IL-6 antibodies, compositions, methods and uses
|
RU2004119816A
(ru)
|
2001-11-28 |
2006-01-10 |
Сандоз АГ (CH) |
Способ культивирования клеток
|
AU2002359816B2
(en)
|
2001-12-21 |
2006-07-13 |
Immunex Corporation |
Methods for purifying protein
|
US20030201229A1
(en)
|
2002-02-04 |
2003-10-30 |
Martin Siwak |
Process for prefiltration of a protein solution
|
CA2473144C
(en)
|
2002-02-05 |
2013-05-28 |
Genentech, Inc. |
Protein purification
|
CA2417689C
(en)
|
2002-03-05 |
2006-05-09 |
F. Hoffmann-La Roche Ag |
Improved methods for growing mammalian cells in vitro
|
US20030190710A1
(en)
|
2002-03-28 |
2003-10-09 |
Devries Ruth L. |
Control of glycoforms in IgG
|
US20040132140A1
(en)
|
2002-04-09 |
2004-07-08 |
Kyowa Hakko Kogyo Co., Ltd. |
Production process for antibody composition
|
EP1543106B1
(en)
|
2002-07-15 |
2007-04-11 |
Immunex Corporation |
Methods and media for controlling sialylation of proteins produced by mammalian cells
|
US7067279B1
(en)
|
2002-08-23 |
2006-06-27 |
Immunex Corporation |
Cell culture performance with betaine
|
US6974681B1
(en)
|
2002-08-23 |
2005-12-13 |
Immunex Corporation |
Cell culture performance with vanadate
|
EP1549342A4
(en)
|
2002-09-17 |
2006-05-10 |
Gtc Biotherapeutics Inc |
ISOLATION OF IMMUNOGLOBULIN MOLECULES TO WHICH HE LACKS DISULFIDE LINKS BETWEEN HEAVY CHAINS
|
US7208585B2
(en)
|
2002-09-18 |
2007-04-24 |
Genencor International, Inc. |
Protein purification
|
US20040162414A1
(en)
|
2002-11-22 |
2004-08-19 |
Santora Ling C. |
Method for reducing or preventing modification of a polypeptide in solution
|
ES2354610T5
(es)
|
2002-12-23 |
2020-09-14 |
Bristol Myers Squibb Co |
Mejora de la calidad del producto en procedimientos de cultivo de células de mamífero para la producción de proteína
|
TWI312368B
(en)
|
2002-12-23 |
2009-07-21 |
Bristol Myers Squibb Compan |
Mammalian cell culture processes for protein production
|
WO2004087761A1
(ja)
*
|
2003-03-31 |
2004-10-14 |
Kirin Beer Kabushiki Kaisha |
ヒトモノクローナル抗体およびヒトポリクローナル抗体の精製
|
DE602004027905D1
(de)
|
2003-05-15 |
2010-08-12 |
Wyeth Llc |
Kontrollierte glukosezufuhr für tierzellkultur
|
EP1648940B1
(en)
|
2003-07-28 |
2016-04-27 |
Genentech, Inc. |
Reducing protein a leaching during protein a affinity chromatography
|
GB2404665B
(en)
|
2003-08-08 |
2005-07-06 |
Cambridge Antibody Tech |
Cell culture
|
JP4740138B2
(ja)
|
2003-10-10 |
2011-08-03 |
ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト |
真核生物細胞におけるポリペプチドの大規模生産方法及びそれに適した培養容器
|
ES2418830T3
(es)
|
2003-10-27 |
2013-08-16 |
Wyeth Llc |
Retirada de agregados de alto peso molecular usando cromatografía de hidroxiapatita
|
US8084032B2
(en)
|
2004-01-21 |
2011-12-27 |
Ajinomoto Co., Inc. |
Purification method which prevents denaturation of an antibody
|
SE0400886D0
(sv)
|
2004-04-02 |
2004-04-02 |
Amersham Biosciences Ab |
Process of purification
|
US20060127950A1
(en)
|
2004-04-15 |
2006-06-15 |
Massachusetts Institute Of Technology |
Methods and products related to the improved analysis of carbohydrates
|
MXPA06012676A
(es)
|
2004-05-04 |
2007-04-02 |
Novo Nordisk Healthcare Ag |
Glucoformas o-enlazadas de polipeptidos y metodos de fabricacion de los mismos.
|
TWI384069B
(zh)
|
2004-08-27 |
2013-02-01 |
Pfizer Ireland Pharmaceuticals |
多胜肽之製法
|
KR101238798B1
(ko)
|
2004-09-30 |
2013-03-04 |
바이엘 헬스케어, 엘엘씨 |
생물학적 분자의 통합된 연속 제조를 위한 장치 및 방법
|
US20060094104A1
(en)
|
2004-10-29 |
2006-05-04 |
Leopold Grillberger |
Animal protein-free media for cultivation of cells
|
JP2006143601A
(ja)
|
2004-11-16 |
2006-06-08 |
Yamato Yakuhin Kk |
血液粘度低下剤
|
US8728828B2
(en)
*
|
2004-12-22 |
2014-05-20 |
Ge Healthcare Bio-Sciences Ab |
Purification of immunoglobulins
|
WO2006084826A1
(en)
|
2005-02-11 |
2006-08-17 |
Novo Nordisk Health Care Ag |
Production of a polypeptide in a serum-free cell culture liquid containing plant protein hydrolysate
|
MX2007011129A
(es)
|
2005-03-11 |
2007-11-06 |
Wyeth Corp |
Un metodo de cromatografia de particion debil.
|
EP1869067A1
(en)
|
2005-04-11 |
2007-12-26 |
Medarex, Inc. |
Protein purification using hcic amd ion exchange chromatography
|
WO2006113743A2
(en)
|
2005-04-18 |
2006-10-26 |
Massachusetts Institute Of Technology |
Compositions and methods for rna interference with sialidase expression and uses thereof
|
US7247457B2
(en)
|
2005-04-26 |
2007-07-24 |
United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention |
Detection and identification of enteroviruses by semi-nested amplification of the enterovirus VP1 protein
|
EP1888638A2
(en)
|
2005-06-03 |
2008-02-20 |
Genentech, Inc. |
Method of producing antibodies with modified fucosylation level
|
EA012801B1
(ru)
|
2005-06-14 |
2009-12-30 |
Эмджен Инк. |
Самобуферирующиеся композиции белков
|
WO2006138737A2
(en)
|
2005-06-17 |
2006-12-28 |
Elan Pharma International Limited |
Methods of purifying anti a beta antibodies
|
LT1917276T
(lt)
|
2005-08-26 |
2018-05-25 |
Ares Trading S.A. |
Glikozilinto interferono beta gavimo būdas
|
AR058140A1
(es)
|
2005-10-24 |
2008-01-23 |
Wyeth Corp |
Metodo de produccion proteica utilizando compuestos anti-senescencia
|
EP4155385A1
(en)
|
2005-12-08 |
2023-03-29 |
Amgen Inc. |
Improved production of glycoproteins using manganese
|
US20070190057A1
(en)
|
2006-01-23 |
2007-08-16 |
Jian Wu |
Methods for modulating mannose content of recombinant proteins
|
JP2009532474A
(ja)
|
2006-04-05 |
2009-09-10 |
アボツト・バイオテクノロジー・リミテツド |
抗体精製
|
RU2008150314A
(ru)
|
2006-05-19 |
2010-06-27 |
Гликофи, Инк. (Us) |
Композиции эритропоэтина
|
JP2010510963A
(ja)
|
2006-06-14 |
2010-04-08 |
グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー |
セラミックヒドロキシアパタイトを使用する抗体の精製方法
|
DK3255141T3
(da)
|
2006-07-13 |
2022-01-31 |
Wyeth Llc |
Fremstilling af antistoffer med forbedret glycosyleringsmønster
|
UA99262C2
(uk)
*
|
2006-08-28 |
2012-08-10 |
Арес Трейдінг С.А. |
СПОСІБ ЗМЕНШЕННЯ КОНЦЕНТРАЦІЇ ВІЛЬНИХ Fc-ЧАСТИН В РІДИНІ, ЩО МІСТИТЬ Fc-ВМІСНИЙ БІЛОК
|
PE20080913A1
(es)
|
2006-09-08 |
2008-08-21 |
Wyeth Corp |
Lavado de arginina en la purificacion de proteinas usando cromatografia de afinidad
|
US10982250B2
(en)
|
2006-09-18 |
2021-04-20 |
Genentech, Inc. |
Methods of protein production
|
EP2064315B1
(en)
|
2006-11-03 |
2015-05-13 |
Wyeth LLC |
Glycolysis-inhibiting substances in cell culture
|
WO2008068879A1
(en)
|
2006-12-06 |
2008-06-12 |
Jcr Pharmaceuticals Co., Ltd. |
Method for production of human erythropoietin
|
WO2008079302A2
(en)
*
|
2006-12-21 |
2008-07-03 |
Millipore Corporation |
Purification of proteins
|
PL2115126T3
(pl)
|
2007-03-02 |
2015-08-31 |
Wyeth Llc |
Zastosowanie miedzi i glutaminianu w hodowli komórkowej do wytwarzania polipeptydów
|
US20100209434A1
(en)
|
2007-03-30 |
2010-08-19 |
Medimmune, Llc |
Antibody formulation
|
KR101811057B1
(ko)
|
2007-04-03 |
2017-12-20 |
옥시레인 유케이 리미티드 |
분자의 글리코실화
|
BRPI0810471A2
(pt)
|
2007-04-16 |
2014-11-11 |
Momenta Pharmaceuticals Inc |
Produtos de glicoproteína definidos e métodos relacionados
|
TW200902708A
(en)
|
2007-04-23 |
2009-01-16 |
Wyeth Corp |
Methods of protein production using anti-senescence compounds
|
WO2008135498A2
(en)
|
2007-05-04 |
2008-11-13 |
Novo Nordisk A/S |
Prevention of protein degradation in mammalian cell cultures
|
EP1988101A1
(en)
|
2007-05-04 |
2008-11-05 |
Novo Nordisk A/S |
Improvement of factor VIII polypeptide titers in cell cultures
|
US20100291065A1
(en)
*
|
2007-05-11 |
2010-11-18 |
Kabanov Alexander V |
Compositions for Protein Delivery and Methods of Use Thereof
|
EP2152856B1
(en)
|
2007-05-11 |
2012-08-29 |
Amgen Inc. |
Improved feed media
|
US20100221823A1
(en)
|
2007-06-11 |
2010-09-02 |
Amgen Inc. |
Method for culturing mammalian cells to improve recombinant protein production
|
KR102262298B1
(ko)
|
2007-07-09 |
2021-06-07 |
제넨테크, 인크. |
폴리펩티드의 재조합 생산 동안의 디술피드 결합 환원의 방지
|
WO2009023562A2
(en)
|
2007-08-09 |
2009-02-19 |
Wyeth |
Use of perfusion to enhance production of fed-batch cell culture in bioreactors
|
WO2009058769A1
(en)
|
2007-10-30 |
2009-05-07 |
Schering Corporation |
Purification of antibodies containing hydrophobic variants
|
BRPI0817182A2
(pt)
*
|
2007-10-30 |
2015-03-17 |
Genentech Inc |
Método para purificar um anticorpo e composições
|
NZ622583A
(en)
|
2007-11-30 |
2015-08-28 |
Abbvie Biotechnology Ltd |
Protein formulations and methods of making same
|
SI2574677T1
(sl)
|
2007-12-27 |
2017-11-30 |
Baxalta GmbH |
Procesi celične kulture
|
WO2009092014A1
(en)
|
2008-01-18 |
2009-07-23 |
Gagnon Peter S |
Enhanced purification of antibodies and antibody fragments by apatite chromatography
|
WO2009114641A1
(en)
|
2008-03-11 |
2009-09-17 |
Genentech, Inc. |
Antibodies with enhanced adcc function
|
WO2009129226A1
(en)
|
2008-04-15 |
2009-10-22 |
Talecris Biotherapeutics, Inc. |
Two-stage ultrafiltration/diafiltration
|
ES2458541T3
(es)
|
2008-05-02 |
2014-05-06 |
Seattle Genetics, Inc. |
Métodos y composiciones para elaborar anticuerpos y derivados de anticuerpos con fucosilación del núcleo reducida
|
WO2010016943A2
(en)
|
2008-08-08 |
2010-02-11 |
Biogen Idec Ma Inc. |
Nutrient monitoring and feedback control for increased bioproduct production
|
KR101843915B1
(ko)
|
2008-08-14 |
2018-04-02 |
제넨테크, 인크. |
고유 단백질 대체 이온 교환 막 크로마토그래피를 이용한 오염물의 제거 방법
|
US8084222B2
(en)
|
2008-09-26 |
2011-12-27 |
Eureka Therapeutics, Inc. |
Methods for generating host cells
|
WO2010141039A1
(en)
|
2008-10-20 |
2010-12-09 |
Abbott Laboratories |
Isolation and purification of antibodies using protein a affinity chromatography
|
SG10201702951RA
(en)
|
2008-10-20 |
2017-06-29 |
Abbvie Inc |
Viral inactivation during purification of antibodies
|
US20100150864A1
(en)
|
2008-10-20 |
2010-06-17 |
Abbott Laboratories, Inc. |
Antibodies that bind to il-18 and methods of purifying the same
|
RU2011120178A
(ru)
|
2008-10-20 |
2012-11-27 |
Эбботт Лэборетриз |
Антитела, которые связываются с il-12, и способы их очистки
|
EP2350130B1
(en)
|
2008-10-31 |
2018-10-03 |
Wyeth LLC |
Purification of acidic proteins using ceramic hydroxyapatite chromatography
|
CN102245206A
(zh)
|
2008-12-09 |
2011-11-16 |
弗·哈夫曼-拉罗切有限公司 |
获得无赋形剂抗体溶液的方法
|
AU2009331897A1
(en)
|
2008-12-22 |
2010-07-01 |
F. Hoffmann-La Roche Ag |
Immunoglobulin purification
|
CA2748807C
(en)
|
2009-01-08 |
2019-01-29 |
Ge Healthcare Bio-Sciences Ab |
Separation method using single polymer phase systems
|
JP5728392B2
(ja)
|
2009-03-05 |
2015-06-03 |
バイオジェン アイデック エムエー インコーポレイティドBiogen Idec Inc. |
免疫グロブリンの精製
|
US9056896B2
(en)
|
2009-03-27 |
2015-06-16 |
Asahi Kasei Medical Co., Ltd. |
Method for removing viruses from high concentration monoclonal antibody solution
|
AR076288A1
(es)
|
2009-04-13 |
2011-06-01 |
Bristol Myers Squibb Co |
Purificacion de proteinas por precipitacion con citrato
|
WO2010122460A1
(en)
|
2009-04-20 |
2010-10-28 |
Pfizer Inc. |
Control of protein glycosylation and compositions and methods relating thereto
|
SG176217A1
(en)
|
2009-05-28 |
2011-12-29 |
Boehringer Ingelheim Int |
Method for a rational cell culturing process
|
CA2763164A1
(en)
|
2009-06-05 |
2010-12-09 |
Momenta Pharmaceuticals, Inc. |
Methods of modulating fucosylation of glycoproteins
|
MX2012000354A
(es)
|
2009-07-06 |
2012-02-01 |
Genentech Inc |
Metodo para cultivar celulas eucarionticas.
|
US20120177640A1
(en)
|
2009-07-24 |
2012-07-12 |
Josef Burg |
Optimizing the production of antibodies
|
WO2011015926A1
(en)
|
2009-08-03 |
2011-02-10 |
Avesthagen Limited |
A process of fermentation, purification and production of recombinant soluble tumour necrosis factor alfa receptor (tnfr) - human igg fc fusion protein
|
JP2013501075A
(ja)
|
2009-08-06 |
2013-01-10 |
ジェネンテック, インコーポレイテッド |
タンパク質精製におけるウイルス除去の改良方法
|
US20110053223A1
(en)
|
2009-08-14 |
2011-03-03 |
Robert Bayer |
Cell culture methods to make antibodies with enhanced adcc function
|
WO2011024025A1
(en)
|
2009-08-28 |
2011-03-03 |
Avesthagen Limited |
An erythropoietin analogue and a method thereof
|
MX2012002565A
(es)
|
2009-09-01 |
2012-05-29 |
Genentech Inc |
Purificacion de proteina mejorada a traves de una elucion de proteina a modificada.
|
US9540426B2
(en)
|
2009-10-06 |
2017-01-10 |
Bristol-Myers Squibb Company |
Mammalian cell culture processes for protein production
|
WO2011049798A1
(en)
|
2009-10-20 |
2011-04-28 |
Merck Sharp & Dohme Corp. |
Use of mixed mode chromatography for the capture and purification of basic antibody products
|
BR112012009289B8
(pt)
|
2009-10-20 |
2021-05-25 |
Abbott Laboratoires |
método para purificar um anticorpo anti-il-13 a partir de uma mistura de amostra que compreende um anticorpo anti-il-13 e pelo menos uma proteína de célula hospedeira (hcp)
|
WO2011065940A1
(en)
|
2009-11-24 |
2011-06-03 |
Biogen Idec Ma Inc. |
Method of supplementing culture media to prevent undesirable amino acid substitutions
|
EP2507627A2
(en)
|
2009-12-04 |
2012-10-10 |
Momenta Pharmaceuticals, Inc. |
Antennary fucosylation in glycoproteins from cho cells
|
US8277649B2
(en)
|
2009-12-14 |
2012-10-02 |
General Electric Company |
Membranes and associated methods for purification of antibodies
|
LT2513134T
(lt)
|
2009-12-18 |
2017-11-27 |
Novartis Ag |
Praplovimo tirpalas ir afininės chromatografijos metodas
|
WO2011087301A2
(ko)
|
2010-01-15 |
2011-07-21 |
성균관대학교산학협력단 |
기체 및 수분 차단용 그래핀 보호막, 이의 형성 방법 및 그의 용도
|
SG184417A1
(en)
|
2010-04-06 |
2012-11-29 |
Heliae Dev Llc |
Selective extraction of proteins from freshwater algae
|
AU2011237442A1
(en)
|
2010-04-07 |
2012-10-18 |
Momenta Pharmaceuticals, Inc. |
High mannose glycans
|
AU2011246502B2
(en)
|
2010-04-26 |
2014-08-28 |
Novartis Ag |
Improved cell cultivation process
|
PT2563904E
(pt)
|
2010-04-26 |
2015-05-12 |
Novartis Ag |
Meio de cultura de células aperfeiçoado
|
KR101989762B1
(ko)
|
2010-05-28 |
2019-06-14 |
제넨테크, 인크. |
락테이트 데히드로게나제 및 피루베이트 데히드로게나제 키나제의 발현의 하향조절에 의한 락테이트 수준의 감소 및 폴리펩티드 생산의 증가
|
CN103080300B
(zh)
|
2010-08-05 |
2015-11-25 |
安姆根有限公司 |
增加细胞培养物的产率和活力的二肽
|
WO2012030512A1
(en)
|
2010-09-03 |
2012-03-08 |
Percivia Llc. |
Flow-through protein purification process
|
CN103154243A
(zh)
|
2010-10-15 |
2013-06-12 |
日本化学研究株式会社 |
糖链的非还原末端为甘露糖残基的糖蛋白的制造方法
|
EP2450375A1
(en)
|
2010-11-09 |
2012-05-09 |
Sandoz Gmbh |
Cell culture medium and process for protein expression, said medium and process comprising a PAM inhibitor
|
WO2012078376A1
(en)
|
2010-12-08 |
2012-06-14 |
Amgen Inc. |
Ion exchange chromatography in the presence of an amino acid
|
WO2012084829A1
(en)
|
2010-12-21 |
2012-06-28 |
F. Hoffmann-La Roche Ag |
Isoform enriched antibody preparation and method for obtaining it
|
MX346663B
(es)
|
2011-03-06 |
2017-03-27 |
Merck Serono Sa |
Lineas de celulas de bajo nivel de fucosa y usos de las mismas.
|
CN103582700B
(zh)
|
2011-03-25 |
2016-08-17 |
弗·哈夫曼一拉罗切有限公司 |
新的蛋白质纯化方法
|
EP2511293A1
(en)
|
2011-04-13 |
2012-10-17 |
LEK Pharmaceuticals d.d. |
A method for controlling the main complex N-glycan structures and the acidic variants and variability in bioprocesses producing recombinant proteins
|
WO2012145682A1
(en)
|
2011-04-21 |
2012-10-26 |
Amgen Inc. |
A method for culturing mammalian cells to improve recombinant protein production
|
EP2702143B1
(en)
|
2011-04-29 |
2018-06-06 |
Biocon Research Limited |
Methods for reducing accumulation of lactate during culturing and method for producing polypeptide
|
US20120283419A1
(en)
|
2011-05-03 |
2012-11-08 |
Avantor Performance Materials, Inc. |
Separation of protein monomers from aggregates by solid weak anion exchange support functionalized with amine moieties
|
EP2707383B1
(en)
|
2011-05-13 |
2018-04-18 |
Biogen MA Inc. |
Methods of preventing and removing trisulfide bonds
|
ES2625045T3
(es)
|
2011-07-01 |
2017-07-18 |
Amgen Inc. |
Cultivo de células de mamífero
|
WO2013006461A1
(en)
|
2011-07-01 |
2013-01-10 |
Biogen Idec Ma Inc. |
Cholesterol-based media supplementals for cell culture
|
CN103717729B
(zh)
|
2011-07-08 |
2017-11-21 |
动量制药公司 |
细胞培养方法
|
WO2013013013A2
(en)
|
2011-07-21 |
2013-01-24 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for producing modified glycoproteins
|
BR112014009178A2
(pt)
|
2011-10-19 |
2018-09-04 |
Roche Glycart Ag |
métodos, uso, receptor e invenção
|